Product Details
| Product Name: Drostanolone propionate | CAS No.: 521-12-0 |
| EC-No.: 208-303-1 | Min. Order: 100KG |
| Purity: 99％ | Supply Ability: 2000kg |
| Release date: 2021/10/29 |
| Dromostanolone Propionate is the propionate salt form of dromostanolone, a synthetic anabolic steroid related to dihydrotestosterone that has antiestrogenic effects. Dromostanolone inhibits the growth of estrogen receptor-presenting breast cancers; its virilizing effects limit its clinical usefulness. Drostanolone propionate is a modified form of drostanolone, where a carboxylic acid ester (propionic acid) has been attached to the 17-beta hydroxyl group.Drostanolone Propionate is a synthetic androgenic anabolic steroid and is approximately 5 times as potent as natural methyltestosterone. |
|
| Like testosterone and other androgenic hormones, dromostanolone binds to the androgen receptor. This causes downstream genetic transcriptional changes. This ultimately causes retention of nitrogen, potassium, and phosphorus; increases protein anabolism; and decreases amino acid catabolism. The antitumour activity of dromostanolone appears related to reduction or competitive inhibition of prolactin receptors or estrogen receptors or production. Specifically, Masteron is the DHT hormone that has been structurally altered by the addition of a methyl group at the carbon 2 position, This protects the hormone from the metabolic breakdown by the 3-hydroxysteroid dehydrogenase enzyme, which is found in the skeletal muscle. |
|
| 17b-Hydroxy-2a-methyl-5a-androstan-3-one propionate, also known as drostanolone propionate, is a synthetic anabolic-androgenic steroid. It has similar properties to dihydrotestosterone. It had been used for the treatment of breast cancer in the past. However, it is now mainly used by athletes and bodybuilder as an anabolic steroid. It has two major effects including enhancing the physical/athletic performance (such as endurance and strength) and enhancing physical health (muscle buildup and fat loss). It should be administrated via intramuscular injection instead of oral taking. |
Company Profile Introduction
Shijiazhuang Erche Biotechnology Co., Ltd is a professional pharmaceutical intermediates company, located in Shijiazhuang City,Hebei Province,China.We are engaged in the manufacturer and supply of pharmaceutical intermediates,organic intermediate, BMK, PMK, API, NMN, nootropics, nutrition ingredients, cosmetic ingredients, sex enhancer, plant extracts,etc.In the past years, our products have spread over more than 50 countries in the world.Most of the products produced and sold are exported abroad,and it is well-received in all around the world for its excellent quality.Our goal is to survive by quality and develop by credit. In the past two years,our products have spread over more than 30 countries in the world, the U.S.A, the Netherlands, Poland, Canada, England, Italy, India, Columbia and so on. We work with friends all over the world to develop the best quality products, the most reasonable prices, safe and effective transportation. Product can be ordered from milligrams to tons to meet the purchase of new and old customers.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $5.60 |
VIP1Y
|
Hubei Pingxiu Technology Co., Ltd.
|
2026-07-25 | |
| $1.00 |
VIP8Y
|
.GZ HONESTCHEM CO.,LTD
|
2026-07-24 | |
| $10.00 |
VIP2Y
|
Ningbo Qingteng Plastic Cost.,Ltd.
|
2026-07-24 | |
| $1.00 |
VIP1Y
|
Tianjin Shunzhicheng Technology Co., Ltd.
|
2026-07-24 | |
|
VIP2Y
|
Shaanxi Xianhe Biotech Co., Ltd
|
2026-07-23 | ||
| $5.00 |
VIP2Y
|
Hebei Jiafan Trading Company Limited
|
2026-07-23 | |
| $30.00 |
Shenzhen Aoxi Technology Co., Ltd.
|
2026-03-26 | ||
| $400.00 |
VIP1Y
|
Hainan Fubai Trading Co., LTD
|
2026-01-14 | |
|
VIP4Y
|
Hangzhou ICH Biofarm Co., Ltd
|
2026-01-04 | ||
| $27.00 |
VIP4Y
|
Anko Intermational Trade Limited
|
2025-07-25 |
China- Since: 2012-03-20
- Address: Building17,Zhuoda Shanghe original community,No.3 Zhaoling North Road, Xinhua District, Shijiazhuang
INQUIRY